BNGO – Bionano Genomics, Inc.
Bionano Genomics, Inc.BNGO
$3.75Name : Bionano Genomics, Inc.
Sector : Healthcare
Industry: Medical Instruments & Supplies
Mark. Cap: $12,615,000.00
EPSttm : -53.53
Bionano Genomics, Inc.
$3.75
1.90%$0.07Float Short %
17.14
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
0.04
EPS Last/This Y
82.7
EPS This/Next Y
2.57
Price
3.77
Target Price
7.33
Analyst Recom
2
Performance Q
-8.09
Relative Volume
0.36
Beta
2.28
Ticker: BNGO
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-05-08 | BNGO | 3.84 | 0.01 | 999.99 | 16944 |
| 2025-05-09 | BNGO | 3.82 | 0.01 | 999.99 | 16943 |
| 2025-05-12 | BNGO | 3.9 | 0.01 | 999.99 | 16961 |
| 2025-05-13 | BNGO | 3.91 | 0.01 | 0.00 | 16951 |
| 2025-05-14 | BNGO | 3.79 | 0.01 | 0.00 | 16951 |
| 2025-05-15 | BNGO | 3.9 | 0.01 | 0.00 | 16962 |
| 2025-05-16 | BNGO | 3.85 | 0.01 | 0.00 | 16917 |
| 2025-05-19 | BNGO | 3.76 | 0.00 | 999.99 | 7571 |
| 2025-05-20 | BNGO | 3.7997 | 0.00 | 999.99 | 7571 |
| 2025-05-21 | BNGO | 3.59 | 0.00 | 999.99 | 7571 |
| 2025-05-22 | BNGO | 3.7 | 0.00 | 999.99 | 7571 |
| 2025-05-23 | BNGO | 3.7 | 0.00 | 999.99 | 7571 |
| 2025-05-27 | BNGO | 3.76 | 0.00 | 0.00 | 7579 |
| 2025-05-28 | BNGO | 3.68 | 0.00 | 0.00 | 7579 |
| 2025-05-29 | BNGO | 3.65 | 0.00 | 0.00 | 7579 |
| 2025-05-30 | BNGO | 3.68 | 0.00 | 0.00 | 7579 |
| 2025-06-02 | BNGO | 3.65 | 0.00 | 0.00 | 7579 |
| 2025-06-03 | BNGO | 3.69 | 0.00 | 0.00 | 7579 |
| 2025-06-04 | BNGO | 3.69 | N/A | N/A | 0 |
| 2025-06-05 | BNGO | 3.67 | N/A | N/A | 0 |
| 2025-06-06 | BNGO | 3.71 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-05-08 | BNGO | 3.84 | - | - | 0.00 |
| 2025-05-09 | BNGO | 3.86 | - | - | 0.00 |
| 2025-05-12 | BNGO | 3.91 | - | - | 0.00 |
| 2025-05-13 | BNGO | 3.90 | - | - | 0.00 |
| 2025-05-14 | BNGO | 3.75 | - | - | 0.00 |
| 2025-05-15 | BNGO | 3.90 | - | - | 0.00 |
| 2025-05-16 | BNGO | 3.82 | - | - | 0.00 |
| 2025-05-19 | BNGO | 3.74 | - | - | 0.00 |
| 2025-05-20 | BNGO | 3.80 | - | - | 0.00 |
| 2025-05-21 | BNGO | 3.58 | - | - | 0.00 |
| 2025-05-22 | BNGO | 3.74 | - | - | 0.00 |
| 2025-05-23 | BNGO | 3.74 | - | - | 0.00 |
| 2025-05-27 | BNGO | 3.77 | 78.0 | - | -5.43 |
| 2025-05-28 | BNGO | 3.69 | 78.0 | - | -5.43 |
| 2025-05-29 | BNGO | 3.70 | 78.0 | - | -5.43 |
| 2025-05-30 | BNGO | 3.67 | 78.0 | - | -5.43 |
| 2025-06-02 | BNGO | 3.68 | 78.0 | - | -5.43 |
| 2025-06-03 | BNGO | 3.69 | 78.0 | - | -5.43 |
| 2025-06-04 | BNGO | 3.70 | 78.0 | - | -5.43 |
| 2025-06-05 | BNGO | 3.68 | 78.0 | - | -5.43 |
| 2025-06-06 | BNGO | 3.77 | 78.0 | - | -5.43 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-05-08 | BNGO | 0.00 | 0.13 | 19.33 |
| 2025-05-09 | BNGO | 0.00 | 0.13 | 19.33 |
| 2025-05-12 | BNGO | 0.00 | 0.13 | 15.74 |
| 2025-05-13 | BNGO | 0.00 | 0.13 | 15.74 |
| 2025-05-14 | BNGO | 0.00 | 0.13 | 15.74 |
| 2025-05-15 | BNGO | 0.00 | 0.13 | 15.74 |
| 2025-05-16 | BNGO | 0.00 | 0.13 | 15.74 |
| 2025-05-19 | BNGO | 0.00 | 0.14 | 14.51 |
| 2025-05-20 | BNGO | 0.00 | 0.14 | 14.51 |
| 2025-05-21 | BNGO | 0.00 | 0.14 | 14.51 |
| 2025-05-22 | BNGO | 0.00 | 0.14 | 14.51 |
| 2025-05-23 | BNGO | 0.00 | 0.14 | 14.51 |
| 2025-05-27 | BNGO | 0.00 | -49.96 | 14.51 |
| 2025-05-28 | BNGO | 0.00 | -49.96 | 17.14 |
| 2025-05-29 | BNGO | 0.00 | -49.96 | 17.14 |
| 2025-05-30 | BNGO | 0.00 | -49.96 | 17.14 |
| 2025-06-02 | BNGO | 0.00 | -52.13 | 17.14 |
| 2025-06-03 | BNGO | 0.00 | -52.13 | 17.14 |
| 2025-06-04 | BNGO | 0.00 | -52.13 | 17.14 |
| 2025-06-05 | BNGO | 0.00 | -52.13 | 17.14 |
| 2025-06-06 | BNGO | 0.00 | -52.13 | 17.14 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.15
Avg. EPS Est. Current Quarter
-2.93
Avg. EPS Est. Next Quarter
-1.11
Insider Transactions
Institutional Transactions
-52.13
Beta
2.28
Average Sales Estimate Current Quarter
6
Average Sales Estimate Next Quarter
7
Fair Value
Quality Score
23
Growth Score
43
Sentiment Score
15
Actual DrawDown %
100
Max Drawdown 5-Year %
-100
Target Price
7.33
P/E
Forward P/E
PEG
P/S
0.44
P/B
0.24
P/Free Cash Flow
EPS
-57.26
Average EPS Est. Cur. Y
-5.43
EPS Next Y. (Est.)
-2.86
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-294.05
Relative Volume
0.36
Return on Equity vs Sector %
-197.7
Return on Equity vs Industry %
-182.4
EPS 1 7Days Diff
-5.4
EPS 1 30Days Diff
-5.43
EBIT Estimation
Bionano Genomics, Inc.Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 98
Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. The company offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. It also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic data from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, the company offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.
stock quote shares BNGO – Bionano Genomics, Inc. Stock Price stock today
news today BNGO – Bionano Genomics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch BNGO – Bionano Genomics, Inc. yahoo finance google finance
stock history BNGO – Bionano Genomics, Inc. invest stock market
stock prices BNGO premarket after hours
ticker BNGO fair value insiders trading